Flutiform Inhalation Aerosol 50μg/5μg
Fluticasone Propionate Micronized 0.05mg · Formoterol Fumarate Hydrate Micronized 0.005mg
Suspension · Prescription medication · Combination
Korea Mundi Pharma Co., Ltd.
MFDS item code 201309962 · Approved 2013.10.29 · Insurance code 678000311
Improvement of asthma symptoms and reduction of inflammation
This medicine is used in the treatment of asthma. It is effective for asthma patients where the combination of a long-acting beta2-agonist and inhaled corticosteroids is deemed appropriate. It alleviates airway inflammation and improves breathing difficulties. It can help relieve the patient's symptoms and improve their quality of life.
Adults (18 years and older): Depending on the severity of the condition, Flutiform Inhalation Aerosol 250μg/10μg should be administered as 2 puffs twice a day. If asthma is properly controlled, conversion to a lower dose is possible, and the dose should be adjusted sequentially up to the dose that effectively controls symptoms.
Children aged 5 years and older: Depending on the severity of the condition, Flutiform Inhalation Aerosol 50μg/5μg should be administered as 2 puffs twice a day. Children and adolescents aged 12 years and older: Depending on the severity of the condition, Flutiform Inhalation Aerosol
This medicine is an inhaler used for the treatment of asthma and chronic lung diseases. It should not be administered to certain patients, such as those with allergies to this medication or its components and should not be used as a first treatment during acute asthma exacerbations. Additionally, caution is needed for patients with moderate to severe bronchiectasis or chronic obstructive pulmonary disease, as there is no experience in administering it to these patients. Patients with specific health conditions such as heart disease, thyroid problems, diabetes, and hypokalemia should use this medicine with caution. In particular, if there is hypokalemia or the risk of it, it is advisable to regularly check blood potassium levels. Patients with pulmonary tuberculosis or pulmonary fungal infections may also have difficulties in treatment with this medicine. During use, this medicine may rarely cause various side effects such as oral candidiasis, palpitations, insomnia, cough, and rashes. If breathing difficulties or unusual bronchospasms occur, usage should be immediately discontinued and medical attention should be sought. This medicine is not appropriate as a first-line treatment for asthma and is recommended to be used with inhaled corticosteroids in patients with severe symptoms. During treatment, the patient's condition should be regularly monitored, and careful management should be undertaken to prevent symptom worsening. Sudden cessation of treatment should be avoided, and it is preferable to gradually reduce the dosage. This medicine should only be used during pregnancy when the benefits outweigh the risks, and it should be restricted especially during labor as it may affect uterine contractions. It is advisable not to use it in children under 5 years of age due to a lack of experience with its administration. In the event of overdose, symptoms such as palpitations, tremors, headaches, and hypokalemia may appear, and immediate medical assistance should be sought. It is important to follow the inhaler usage instructions accurately, and to rinse the mouth with water after use to prevent oral infections. Finally, this medicine may interact with other beta2 agonists or specific medications; hence, inform healthcare professionals of any other medications being taken.
Hives, severe swelling (edema), chest tightness, breathing difficulties, cold sweat, pallor, severe rash with high fever, blistering, skin peeling, pain in mucous membranes of the mouth/eyes, shortness of breath or difficulty breathing, asthma attacks, breathing abnormalities associated with cough and fever, yellowing of the skin or eyes (jaundice), extreme lethargy, sudden and severe headaches, thunderclap headaches, seizures, confusion of consciousness, visual disturbances, paralysis, urination
Not everyone experiences these, and they can vary from person to person.
This medicine should be stored away from direct sunlight and it is important to maintain a temperature below 25 degrees Celsius. Do not refrigerate or freeze, and ensure it is stored in a tightly sealed container to prevent exposure to air.
A metered dose inhaler containing a white to off-white suspension in an aluminum canister with a dose control valve.
120 doses per canister
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Fluticasone Propionate Micronized 0.05mg · Formoterol Fumarate Hydrate Micronized 0.005mg
Suspension · Prescription medication · Combination
Korea Mundi Pharma Co., Ltd.
Fluticasone Propionate Micronized 0.25mg · Formoterol Fumarate Hydrate Micronized 0.01mg
Suspension · Prescription medication · Combination
Korea Mundi Pharma Co., Ltd.
Fluticasone Propionate Micronized 0.125mg · Formoterol Fumarate Hydrate Micronized 0.005mg
Suspension · Prescription medication · Combination
Korea Mundi Pharma Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.